| Accountable Care Organization 2012 Quality Performance Report Summary Statistics Report | |||||
| TP-ACO L.L.C. | |||||
| Domain | Measure Number | Measure Name | TP-ACO Performance Rate | Mean Performance Rate All ACOs | |
| Patient/Caregiver Experience | ACO-1 | Getting Timely Care, Appointments, and Information | 85.28 | 81.69 | |
| ACO-2 | How Well Your Doctors Communicate | 94.44 | 92.84 | ||
| ACO-3 | Patients’ Rating of Doctor | 92.97 | 91.86 | ||
| ACO-4 | Access to Specialists | 86.71 | 85.11 | ||
| ACO-5 | Health Promotion and Education | 59.96 | 56.61 | ||
| ACO-6 | Shared Decision Making | 76.65 | 73.99 | ||
| ACO-7 | Health Status/Functional Status | 69.73 | 70.35 | ||
| Care Coordination/Patient Safety | ACO-8 | Risk Standardized, All Condition Readmissions | 16.29 | 15.42 | |
| ACO-9 | ASC Admissions: COPD or Asthma in Older Adults | 1.40 | 1.13 | ||
| ACO-10 | ASC Admission: HF | 1.11 | 1.09 | ||
| ACO-11 | Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment | 38.78% | 59.87% | ||
| ACO-12 | Medication Reconciliation | 98.10% | 72.37% | ||
| ACO-13 | Falls: Screening for Fall Risk | 22.35% | 28.27% | ||
| Preventive Health | ACO-14 | Influenza Immunization | 52.61% | 50.58% | |
| ACO-15 | Pneumococcal Vaccination | 56.99% | 48.62% | ||
| ACO-16 | Adult Weight Screening and Follow-up | 50.57% | 53.91% | ||
| ACO-17 | Tobacco Use Assessment and Cessation Intervention | 94.63% | 80.12% | ||
| ACO-18 | Depression Screening | 28.34% | 22.48% | ||
| ACO-19 | Colorectal Cancer Screening | 66.39% | 50.21% | ||
| ACO-20 | Mammography Screening | 65.58% | 62.23% | ||
| ACO-21 | Proportion of Adults who had blood pressure screened in past 2 years | 87.41% | 71.56% | ||
| At Risk Population | Diabetes Composite | Beneficiaries with diabetes who met of all the following criteria: | 12.00% | 22.78% | |
| ACO-22 | Hemoglobin A1c Control (HbA1c) (<8 percent) | 54.40% | 64.46% | ||
| ACO-23 | Low Density Lipoprotein (LDL) (< 100 mg/dL) | 38.60% | 52.99% | ||
| ACO-24 | Blood Pressure (BP) < 140/90 | 49.80% | 66.04% | ||
| ACO-25 | Tobacco Non-Use | 74.00% | 71.72% | ||
| ACO-26 | Aspirin Use | 56.35% | 72.24% | ||
| ACO-27 | Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) | 36.00% | 25.94% | ||
| ACO-28 | Percent of beneficiaries with hypertension whose BP < 140/90 | 46.80% | 63.22% | ||
| ACO-29 | Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl | 36.72% | 52.02% | ||
| ACO-30 | Percent of beneficiaries who use Aspirin or other antithrombotic | 61.85% | 72.60% | ||
| ACO-31 | Beta-Blocker Therapy for LVSD | 74.03% | 79.60% | ||
| CAD Composite | Percent of beneficiaries with CAD who met all of the following criteria: | 62.41% | 61.69% | ||
| ACO-32 | Drug Therapy for Lowering LDL-Cholesterol | 66.83% | 69.67% | ||
| ACO-33 | (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) | 75.49% | 69.71% | ||
